Drugmakers and pharmacists battle over who gets to make obesity drugs
The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from making cheaper copies. They argue they can keep up with demand on their own.
The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from making cheaper copies. They argue they can keep up with demand on their own.
(Image credit: James Manning/PA Images)
What's Your Reaction?
CryptoFortress
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.
